rishnnia murugan, farinawati yazid, nurrul shaqinah nasruddin, nur najmi mohamad anuar.  (2022).  effects of nanohydroxyapatite incorporation into glass ionomer cement (gic).  - minerals.  1-10. 

afifah zahirah abd rami, adila a. hamid, nur najmi mohamad anuar, amilia aminuddin, azizah ugusman.  (2022).  exploring the relationship of perivascular adipose tissue inflammation and the development of vascular pathologies.  - mediators of inflammation.  1-16. 

nor anizah mohd nor, siti balkis budin, satirah zainalabidin, juriyati jalil, syaifuzah sapian, fatin farhana jubaidi, nur najmi mohamad anuar.  (2022).  the role of polyphenol in modulating associated genes in diabetes-induced vascular disorders.  - international journal of molecular sciences.  1-24. 

fatin farhana jubaidi, satirah zainalabidin, izatus shima taib, zariyantey abdul hamid, nur najmi mohamad anuar, juriyati jalil, nor anizah mohd nor, siti balkis budin.  (2022).  the role of pkc-mapk signalling pathways in the development of hyperglycemia-induced cardiovascular complications.  - international journal of molecular sciences.  1-24. 

adila a. hamid, amilia aminuddin, nur najmi mohamad anuar, nur izzati mansor, mohd faizal ahmad, mohammed s. m. saleh, mohd helmy mokhtar and azizah ugusman.  (2022).  persicaria minor (huds.) opiz prevents in vitro atherogenesis by attenuating tumor necrosis factor-alpha-induced monocyte adhesion to human umbilical vein endothelial cells.  - life.  1-12. 

syaifuzah sapian, izatus shima taib, haliza katas, jalifah latip, satirah zainalabidin, zariyantey abd hamid, nur najmi mohamad anuar, siti balkis budin.  (2022).  the role of anthocyanin in modulating diabetic cardiovascular disease and its potential to be developed as a nutraceutical.  - pharmaceuticals.  1-21. 

nur syahidah nor hisam, azizah ugusman, nor fadilah rajab, mohd faizal ahmad, michael fenech, liew sze ling and nur najmi mohamad anuar.  (2021).  combination therapy of navitoclax with chemotherapeutic agents in solid tumors and blood cancer: a review of current evidence.  - pharmaceutics.  1-13. 

nur najmi mohamad anuar, nur syahidah nor hisam, liew sze ling, azizah ugusman.  (2020).  clinical review: navitoclax as a pro-apoptotic and anti-fibrotic agent.  - frontiers in pharmacology.  1-16.